Promising New Treatments for Parkinson’s: What’s in the Clinical Trial Pipeline? There remains an urgent unmet need for Parkinson’s disease (PD) treatments that slow or halt the underlying neurodegenerative process that leads to disease progression. Much research is focused on this, with clinical trials underway. It is also critical that medications continue to be developed […]
Understanding the Different Forms of Carbidopa/Levodopa: Additional Questions Answered
Exploring the New Forms of Carbidopa/Levodopa with Dr. Vaou On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with Dr. Okeanis Vaou, a movement disorders specialist, about the various new formulations of carbidopa/levodopa that are available, including Crexont® and Vyalev®, among others. Carbidopa/levodopa is the mainstay of treatment for Parkinson’s disease (PD) and is […]
The History of the American Parkinson Disease Association
The American Parkinson Disease Association (APDA) has long been committed to providing the support, education, research, and community that helps everyone impacted by Parkinson’s disease (PD) live life to the fullest – a legacy that dates back to APDA’s founding in 1961, when a young woman named Sophia Esposito Maestrone sought to honor the memory […]
Early signs of Parkinson’s disease
Women & PD Research Progress: Catching Up with APDA Researcher Dr. Roberta Marongiu
Advancing Parkinson’s Disease Research: APDA’s Commitment to Innovation The American Parkinson Disease Association (APDA) is committed to furthering Parkinson’s disease (PD) research and proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and finding the cure(s) for PD. Our Centers for Advanced Research, along with a variety of […]
Parkinson’s Disease and the Loss of Independence: Coping Strategies & Support
Navigating Independence with Parkinson’s Disease As a progressive neurodegenerative movement disorder, Parkinson’s disease (PD) comes hand in hand with an increasing loss of independence as the disease advances, resulting in a gradual loss of independence. This is often difficult to navigate and can sometimes contribute further to the depression and anxiety that many people experience […]
Can exercise slow down Parkinson’s progression? The SPARX3 trial investigates
The SPARX3 Research Trial Investigates How Exercise Helps Parkinson’s People with Parkinson’s disease (PD) are constantly being told, by family, friends, doctors and the APDA community, that exercise is a vital part of any Parkinson’s treatment plan and is essential to functioning at your best with PD. To support this claim, there are many clinical […]
Tracking the Impact: 2024 APDA-funded Parkinson’s Research
APDA proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and finding the cure(s) for Parkinson’s disease (PD). APDA is committed to scientific research and has been a funding partner in many major scientific breakthroughs related to Parkinson’s disease, investing more than $62 million in research since […]
Creativity in People with Parkinson’s Disease
The benefits of artistic activities for people with Parkinson’s Parkinson’s disease (PD) is a complicated and long-term condition that often impacts both physical and mental health. Traditional medical and surgical treatments are not always enough to help people with PD live life to the fullest, and creative activities – from visual arts and music to […]
The complicated world of genetic testing for Parkinson’s disease
Categories
- Advanced Parkinson’s
- Care Partners
- Clinical Trials & PD
- COVID-19 & PD
- Digital Digest Articles
- Exercise
- Genetics & PD
- Intimacy & PD
- Living with Parkinson's
- Medication
- News
- Press Release
- Profiles in Parkinson's
- Research
- Risk Factors for Parkinson's
- Simplified Chinese
- Spanish
- Speech & PD
- Symptoms
- Training Courses
- Treatments
- Uncategorized
- Veterans
- What is Parkinson's
- Young Onset Parkinson's